DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?

Major depressive disorder (MDD) is a debilitating psychiatric disorder, the third leading global cause of disability. Regarding aetiopathogenetic mechanisms involved in the onset of depressive disorders, the interaction between genetic vulnerability traits and environmental factors is believed to pl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current neuropharmacology Jg. 20; H. 12; S. 2267
Hauptverfasser:	Paoli, Caterina, Misztak, Paulina, Mazzini, Giulia, Musazzi, Laura
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United Arab Emirates 15.11.2022
Schlagworte:	Animals Antidepressive Agents - pharmacology Antidepressive Agents - therapeutic use Biomarkers Depression - genetics Depressive Disorder, Major - drug therapy Depressive Disorder, Major - genetics DNA Epigenesis, Genetic Phenotype DNA methylation Depression animal model biomarker epigenetics antidepressant
ISSN:	1875-6190, 1875-6190
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!